Pfizer Inc (MIL:1PFE)
€ 24.62 -0.33 (-1.32%) Market Cap: 140.00 Bil Enterprise Value: 193.63 Bil PE Ratio: 34.77 PB Ratio: 1.58 GF Score: 59/100

Pfizer Inc at Bank of America Global Healthcare Conference (Virtual) Transcript

Sep 15, 2021 / 03:45PM GMT
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst

Okay. Great. Welcome to the mid-day sessions, midday East Coast at the end of the day, London time, but it's BofA Global Healthcare Conference. My name is Geoff Meacham. I'm the senior biopharma analyst here at BofA. I also have Bill Maughan for my team on. And we're thrilled to have Pfizer with us today. And speaking on behalf of Pfizer, we have Angela Hwang, who is Group President Pfizer Biopharmaceuticals. Angela, great to see you.

Angela Hwang
Pfizer Inc. - Group President, Pfizer Biopharmaceuticals Group

Thanks, Geoff. Thanks for having me here.

Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst

We also have Chris Stevo from the IR team. And I'll hand over to Chris to say a couple of things from a disclaimer perspective, then we'll get right into questions.

Christopher J. Stevo
Pfizer Inc. - Senior VP & Chief IR Officer

I have the fun duty of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot